Rewalk Robotics (RWLK) Posts Earnings Results, Beats Estimates By $0.01 EPS

Rewalk Robotics (NASDAQ:RWLK) posted its earnings results on Thursday. The medical device company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01, Morningstar.com reports. The business had revenue of $1.62 million for the quarter, compared to analyst estimates of $2.12 million. Rewalk Robotics had a negative return on equity of 3,654.32% and a negative net margin of 365.87%. Rewalk Robotics updated its FY 2018 guidance to EPS.

RWLK remained flat at $$0.67 during trading on Friday. The company had a trading volume of 433,778 shares, compared to its average volume of 191,463. The company has a market cap of $25.92 million, a P/E ratio of -0.68 and a beta of 0.77. Rewalk Robotics has a twelve month low of $0.65 and a twelve month high of $1.60.

A number of research firms recently weighed in on RWLK. Zacks Investment Research lowered Rewalk Robotics from a “buy” rating to a “hold” rating in a report on Thursday, October 25th. Oppenheimer set a $2.00 target price on Rewalk Robotics and gave the stock a “buy” rating in a report on Friday, August 24th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company’s stock. Rewalk Robotics presently has an average rating of “Hold” and an average price target of $1.85.

COPYRIGHT VIOLATION NOTICE: “Rewalk Robotics (RWLK) Posts Earnings Results, Beats Estimates By $0.01 EPS” was first posted by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.americanbankingnews.com/2018/11/10/rewalk-robotics-rwlk-posts-earnings-results-beats-estimates-by-0-01-eps.html.

About Rewalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Read More: How Important is Technical Analysis of Stocks

Earnings History for Rewalk Robotics (NASDAQ:RWLK)

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply